FIELD: medicine.
SUBSTANCE: invention refers to chemical-pharmaceutical industry, and concerns nasal pharmaceutical compositions for treating allergic rhinitis, containing beclometasone in the form of aqueous suspension with a specific profile of particle size distribution.
EFFECT: invention provides higher bioavailability, improved effectiveness or long therapeutic effect of the pharmaceutical composition in intranasal introduction.
49 cl, 1 ex, 2 tbl, 4 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| NASAL PHARMACEUTICAL COMPOSITIONS AND METHODS OF APPLICATION THEREOF | 2004 |
|
RU2380090C2 |
| COMPOSITIONS AND METHODS OF TREATING RHINOSINUSITIS | 2004 |
|
RU2410083C2 |
| COMBINATION OF LEVOCABASTINE AND FLUTICASONE FUROATE FOR THE TREATMENT OF INFLAMMATORY AND/OR ALLERGIC CONDITIONS | 2013 |
|
RU2652352C2 |
| TREATMENT OF ALLERGIC RHINITIS IN PEDIATRIC CATEGORY USING A COMBINATION OF MOMETASONE AND OLOPATADINE | 2019 |
|
RU2798030C2 |
| TREATMENT OF ALLERGIC RHINITIS USING A COMBINATION OF MOMETASONE AND OLOPATADIN | 2014 |
|
RU2799761C2 |
| TREATMENT OF ALLERGIC RHINITIS USING COMBINATION OF MOMETASONE AND OLOPATADINE | 2014 |
|
RU2686670C2 |
| AQUEOUS AEROSOL PREPARATION | 2004 |
|
RU2363449C2 |
| AXELASTIN AND STEROIDS COMBINATION | 2003 |
|
RU2361593C2 |
| INHALATION PARTICLES CONTAINING COMBINATION OF ANTICHOLINERGIC, CORTICOSTEROID AND BETA-ADRENERGIC AGENTS | 2015 |
|
RU2697867C2 |
| METHOD FOR PRODUCING CARRIER PARTICLES FOR DRY POWDERS FOR INHALATIONS | 2011 |
|
RU2585101C2 |
